Issue 97, 2015

The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration

Abstract

Study of the copper binding properties of metformin is important for revealing its mechanism of action as a first-line type-2 diabetes drug. A quantitative investigation of interactions between metformin and L-cysteine–copper complexes was performed. The results suggest that metformin could interact with biological copper, which plays a key role in mitochondrial function.

Graphical abstract: The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration

Supplementary files

Article information

Article type
Communication
Submitted
26 May 2015
Accepted
07 Sep 2015
First published
07 Sep 2015

Chem. Commun., 2015,51, 17313-17316

Author version available

The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration

X. Quan, R. Uddin, A. Heiskanen, M. Parmvi, K. Nilson, M. Donolato, M. F. Hansen, G. Rena and A. Boisen, Chem. Commun., 2015, 51, 17313 DOI: 10.1039/C5CC04321B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements